Why Expanded Indications are Fueling the Rapid Growth of the Baricitinib Market
The therapeutic footprint of Janus kinase inhibitors is widening as we move through 2026. In the Baricitinib Market the focus has shifted from managing traditional autoimmune conditions to capturing new, high-demand dermatological sectors. While originally established as a powerful treatment for rheumatoid arthritis, baricitinib is now seeing a massive surge in adoption for severe alopecia...
0 Комментарии 0 Поделились 5 Просмотры 0 предпросмотр